1000
Asia Pacific J Clin Nutr (1997) 6(2): 122-142 (part 1)
Asia Pacific J Clin
Nutr (1997) 6(2): 122-142

Review article
Nutrition and cardiovascular disease:
an Asia Pacific perspective
Geok Lin Khor PhD
Department of Nutrition and Community
Health, Faculty of Biomedical and Health Sciences, Universiti Putra
Malaysia, Serdang, Malaysia
Plenary Lecture presented at the Satellite
Meeting of the Asian Congress of Nutrition on "Nutrition, Body
Composition and Ethnicity" in Tianjin, China on 5th October 1995.
Changes in the dietary intake patterns of countries
in the Asia Pacific region are considered in relation to trends
of cardiovascular disease mortality. Cardiovascular disease now
constitutes the major cause of mortality in many of the countries
of the region. The mortality rate for coronary heart disease (CHD)
has been on the decline since the mid-1960s in countries such as
Australia, New Zealand and Japan, while a decline in other countries,
including Singapore and Hong Kong, appears to be occurring about
two decades later after a delayed increase. In contrast, countries
like Malaysia and China have had and continue an upward trend for
CHD mortality. Nonetheless, the mortality rates due to CHD in New
Zealand, Australia, Singapore followed by Hong Kong rank among the
highest in the region. In China, Taiwan and Japan, death due to
cerebrovascular disease remains a major cause of death, although
the latter two countries have undergone a significant decline in
stroke death rates since 1970.
The intakes of fat from land animal products, fish
and vegetable oils, depending on fatty acid patterns and, possibly
other constituents, are candidate contributors to the different
atherogenic and thrombotic effects. Countries which have a higher
mortality from CHD tend to have a higher intake of energy from fat
and proportion of fat from animal products. These fat intakes may
operate to increase hypercholesterolemia and overweight in various
countries. Again, intakes of other food items and constituents used
in the region such as soybeans, dietary antioxidants in fruits,
vegetables, seeds, cereals, nuts and tea and alcohol consumption
are candidate cardio-protectants.
The wide dietary scope of Asia Pacific populations,
from diverse socio-cultural backgrounds, and at different levels
of economic and technological development poses several analytic
challenges and opportunities. Future research should improve the
datasets and think laterally about pathogenesis and intervention.
Key words: Diet, cardiovascular
disease, Asia Pacific, epidemiology, risk factors, coronary heart
disease, antioxidants, lipids, hypertension, soy beans, obesity, diabetes
Introduction
1000
International comparisons of the patterns and determinants
of cardiovascular disease (CVD) go back more than 60 years ago. Raab
in 1932, as quoted by Stamler1, noted "the relative
rarity of atherosclerosis and hypertension among the chiefly vegetable-consuming
inhabitants of China, Africa, Dutch East India, and the enormous frequency
of arteriosclerosis and hypertension among the peoples of Europe and
North America who consume large quantities of eggs, butter....".
Stamler1 also quoted Rosenthal who had observed in 1934
that "in no race for which a high cholesterol intake (in the
form of eggs, butter and milk) and fat intake are recorded is atherosclerosis
absent....".
The epidemiologic relationship between diet and CVD
in Western countries has been extensively researched, following the
Framingham Study which began in the 1940s2. Several cross-cultural
comparisons have also been undertaken in these countries such as the
Seven Countries Study3; the International Atherosclerosis
Project4; the Ni-Hon-San Study5; the Boston-Ireland
Diet-Heart Study6, and the WHO MONICA Project7.
These studies have contributed a wealth of information towards the
understanding of the roles of various risk factors of CVD, which include
cigarette smoking, sedentariness, obesity, hypertension, diabetes
and dyslipidaemia besides dietary factors.
Compared to Western countries, there are not as many
studies pertaining to CVD and its risk factors in the developing countries.
There is also a paucity of reliable data on deaths due to CVD in these
countries due to a lack of complete vital registration and medical
certification of deaths. For example, among countries of the WHO Western
Pacific region, cause-of-death statistics are available only for 23%
of the population, as compared to 94% for Europe8. In comparison,
in the industrialised countries which include Japan, Australia and
New Zealand, cause-specific mortality data by age and sex are available
in the WHO mortality data base, some cases extending back to 1950.
In industrialised countries, deaths due to CVD account
for almost half of all deaths8. Within this category, coronary
heart disease (CHD) or ischaemic heart disease is the single most
important cause of mortality. In 1990, out of 10.9 million deaths
in industrialised countries, just over 5.3 million were due to CVD,
primarily CHD (2.7 million or 25% of total deaths) and cerebrovascular
disease (1.4 million or 13% of total deaths). Since the mid 1960s,
a number of these countries including Japan, United States and Australia
have experienced considerable decline in CVD mortality9.
In the case of developing countries, however, Bulato, Lopez and Stephens10
estimated that by the year 2015, the proportion of deaths caused by
CVD will be almost twice the level in 1985 (Table 1). This is not
unexpected given that the majority of the people in the developing
countries are under 35 years of age and CVD risk factors like obesity
and hypercholesterolemia are already prevalent among the young.
Table 1. Estimated and projected distribution
of the major causes of death.
| Disease category |
Developed countries
|
Developing countries
|
| |
1985
|
2015
|
1985
|
2015
|
| |
%
|
%
|
%
|
%
|
| Infectious & parasitic
diseases |
9
|
7
|
36
|
19
|
| Neoplasms |
18
|
18
|
7
|
14
|
| Diseases of circulatory
system &certain degenerative diseases |
50
|
53
|
19
|
35
|
| Complications of pregnancy |
0
|
0
|
1
|
1
|
| Perinatal conditions |
1
|
1
|
8
|
5
|
| Injury and poisoning |
6
|
5
|
< 1000 font size="2">8
|
7
|
| All other and unknown
causes |
15
|
16
|
21
|
19
|
| All causes |
100
|
100
|
100
|
100
|
Source: Bulato, Lopez & Stephens, 1989 (Ref10)
The Asia Pacific region represents an important area
in terms of its economic, technological, and demographic resources.
The population in this region accounts for about one-third of the
total global population (Table 2). These countries have a multitude
of ethnic groups with widely diverse dietary habits. The health risks
faced by these countries range from traditional environmental exposures
(such as poor sanitation), and modern agricultural hazards (such as
pesticide contamination of water and food), to those associated with
urbanisation and industrialisation (such as chronic non-communicable
diseases). Countries in this region also differ widely with respect
to their nutritional status, ranging from countries still grappling
with problems of undernutrition (Papua New Guinea, Indonesia, the
Philippines), to those who are beset more with health problems associated
with overnutrition (Singapore, Hong Kong, Australia, New Zealand).
In between are countries undergoing nutrition transition faced with
both the "old" problems of nutrient deficiencies and the
new problems of overnutrition (China, Malaysia, Thailand, Taiwan).
Table 2. Demographic indicators of some Asia
Pacific countries
| Country |
Population
|
Life expectancy at birth
|
| |
(million)
|
Men
|
Women
|
| |
|
1993
|
1993
|
| China |
1,205.2
1000 |
69.0
|
73.0
|
| Indonesia |
194.6
|
62.0
|
65.0
|
| Japan |
125.0
|
76.3
|
82.5
|
| Vietnam |
71.0
|
62.0
|
67.0
|
| Philippines |
66.5
|
63.0
|
67.0
|
| Thailand |
56.9
|
65.7
(1992)
|
70.4
(1992)
|
| Republic of Korea |
44.5
|
69.0
|
76.0
|
| Malaysia |
19.2
|
69.0
|
73.0
|
| Australia |
17.8
|
73.7
(1992)
|
80
(1992)
|
| Pacific Islands Total
Papua New Guinea
Fiji
Solomon Islands
|
6.7
4.2
0.8
0.4
|
55.0
70.0
69.0
|
57.0
74
73
|
| Hong Kong |
5.9
|
75.0
|
81.0
|
| New Zealand |
3.5
|
72.0
|
78.0
|
| Singapore |
2.8
|
73.7
(1992)
|
78.3
(1992)
|
Source: Statistical Yearbook for Asia and the Pacific
United Nations ESCAP, Bangkok, 1994
This article compares the CVD situation among the
countries in the Asia Pacific region, focusing on the patterns of
mortality due to coronary heart disease (CHD) and cerebrovascular
disease. The prevalence of dietary risk factors of CVD in the various
countries in the region is discussed at length. Included are fat intake
from animal products, fish and vegetable oils. Also presented in the
discussion are other dietary items with CVD implications such as vitamin
antioxidants namely, vitamin E, b-carotene and vitamin C, soybean and alcohol consumption. Cardiovascular
disease risk factors related to diet as exemplified by obesity and
diabetes mellitus are also discussed.
Limitations
of review
A comparison of the CVD situation in such a widely
diverse array of backgrounds poses several challenges. A major constraint
lies in the limited intercountry comparability of mortality data.
Death attributed to CVD in one country might be attributed to a different
form of heart disease in another country . This variation can be due
to differences in diagnosis and terminology on death certificates,
or in the coding methodology across nations as applied to the International
Classification of Diseases (ICD)11. The lack of medical
personnel to certify the underlying cause of death and the unavailability
of diagnostic aids especially in rural areas can also affect the quality
and hence the comparability of mortality data internationally. Low
figures reported may not necessarily reflect low incidence or mortality
levels but may be due to inaccuracies in data collection12.
In this article, two major types of CVD, coronary
heart disease and cerebrovascular disease, are highlighted. For 1000
the purpose of intercountry comparisons here, mortality due to CHD
refers to codes 410-414 in both the Eighth Revision (introduced in
1968/70) and the Ninth Revision (introduced in 1979/80) of the ICD.
The ICD codes for cerebrovascular disease are 430-438.
The trends in CHD mortality have been well documented
for some countries in the region including Australia, New Zealand,
Japan and Singapore. However, inter-report comparison faces the constraint
of reports covering varying age groups and time periods. For example,
while some reports showed CHD mortality trends for subjects aged 40-69,
others described the trends for ages 45-6411,13. Different
reports described different age intervals (ages 30-34, or 30-39 or
30-44), thereby rendering direct comparisons difficult. Some reports
present mortality rates as age-adjusted to the world population standard14,
while individual country reports often are not presented in this manner.
A substantial amount of data was drawn from the publications
of the World Health Organisation and the Food and Agriculture Organisation.
A constraint arises for Taiwan which is not included in these reports
as it is not a member of the United Nations. The availability of data
for Taiwan and other countries was dependent upon reports based on
MEDLINE search output.
In light of the lack of reliable primary dietary data
from surveys for several countries in the region, food availability
data from FAO Food Balance Sheets are used to compare the dietary
patterns and changes of Asia Pacific countries. The shortcomings of
food balance sheet data or "food disappearance" data are
well recognised, especially with regards to the data not reflecting
distribution and accessibility by different socio-economic groups.
The data may over-estimate actual consumption by as much as 25%15.
Nonetheless, food balance sheets represent a useful source of information
from which inter-country comparisons of dietary trends and patterns
can be made.
Cardiovascular
disease mortality
Given the diverse socio-economic background of Asia
Pacific countries, it is not surprising that the region has a wide
range in CVD mortality rates and trends. In New Zealand and Australia,
the proportion of mortality attributed to CVD for men accounts for
over 40% of total mortality (Table 3). This level is in line with
that for industrialised countries (49%)16. However, Japan
is an exceptional case among industrialised countries in that its
mortality due CVD accounts for less than 30% of total death cases.
This level in Japan places it among less industrialised countries
such as Malaysia and the Philippines. In comparison, Singapore and
the urban parts of China have intermediate mortality levels for CVD
which lie between 30-40% of total deaths.
The CVD proportionate mortality for women in the Asia
Pacific countries shows a similar pattern as that for men, with New
Zealand topping the countries followed by Australia and Singapore
(Table 3). Women in Japan, the Philippines and Thailand rank among
the lowest in terms of the proportion of death cases due to CVD.
Taylor, Lewis and Levy17 in reporting the
mortality patterns in the Pacific Islands, revealed that the proportionate
mortality for CVD is relatively high in the more developed islands
associated with the United States, New Zealand and among the New Caledonian
Europeans. In comparison, the less developed Melanesian countries
manifest higher proportional mortality from infectious disease.
Table 3. Proportionate mortality from cardiovascular
diseases.
| |
Male
|
Female
|
| |
Cardio-vascular disease
|
Coronary heart disease
|
Cerebro vascular disease
|
Cardio-vascular disease
|
Coronary heart disease
|
Cerebro vascular disease
|
| Industrialised countries
1990* |
48.6
|
21.4
|
10.5
|
59.0
|
21.9
|
16.8
|
| New Zealand |
45.8
|
34.7
|
4.8
|
30.3
|
16.7
|
7.4
|
| Australia |
41.7
|
31.1
|
5.1
|
28.8
|
16.6
|
7.1
|
| China (Beijing) |
40.6
|
10.4
|
20.8
|
1000
45.8
|
7.3
|
24.3
|
| Singapore** |
35.1
|
19.7
|
9.8
|
39.0
|
17.9
|
14.5
|
| Malaysia*** |
29.1
|
12.7
|
7.5
|
30.1
|
9.4
|
10.3
|
| Japan |
27.7
|
5.5
|
12.3
|
26.8
|
3.5
|
13.6
|
| Philippines** |
25.6
|
6.8
|
5.5
|
28.1
|
6.4
|
5.9
|
| Thailand** |
17.3
|
0.4
|
2.7
|
15.3
|
0.4
|
2.2
Sources: World Health Statistics Annual, 1989 (ref
18); *Lopez, 1990 (ref 16); **SEAMIC Health Statistics, 1993 (ref
19); ***Vital Statistics Peninsular Malaysia, 1991 (ref 20).
The low proportionate mortality for CVD in some countries
like Thailand, Malaysia and Indonesia could be due in part to the
fact that these countries have a low proportion of death cases that
are medically inspected and certified. For example, in Malaysia, only
about 41% of the annual total deaths are medically certified21,
compared to 65-70% in Singapore22 and 100% in Australia,
New Zealand and Japan18. For countries with a relatively
low rate of medical certification, the cause-of-death statistics refer
largely to only the urban population or selected sub-population groups.
Hence, the interpretation of such data should be circumspect.
Mortality
rates for coronary heart disease
One may arbitrarily categorise the Asia Pacific countries
into three categories according to their mortality rates for CHD for
men. The first category is comprised of New Zealand, Australia and
Singapore with CHD mortality rates exceeding 100 per 100,000 population
for all ages. As shown in Table 4, New Zealand is first with a mortality
rate of 228 per 100,000 population for men and 173 for women followed
by Australia with 191 and 161 for men and women, respectively. Singapore
lies third with values of 104 for men and 77 for women, respectively.
When compared on the basis of age-standardised to world standard population14,
however, the CHD mortality in Singapore is similar to Australia, that
is, 132 (men) and 78 (women) for Singapore and 140 (men) and 73 (women)
for Australia (Table 5). The respective figures for New Zealand with
the highest mortality rates are 173 and 84 per 100,000.
Hong Kong belongs to the next highest category of
CHD mortality rates with a value of between 50-100 per 100,000 population
(Table 4). Heart diseases with CHD as the major category have become
the second leading cause of mortality during the past 20 years23.
Socio-economic class is known to influence CHD mortality patterns.
It has been reported in Hong Kong that the more affluent population
groups, which include professional, administrative and managerial
workers, have higher standardised mortality rates for CHD than do
manual and agricultural workers24,25.
The third category, with the lowest range of CHD mortality
rates of below 50 per 100,000, includes Japan, China, the Philippines,
Malaysia, Thailand (Table 4) and Indonesia26. Japan stands
out as an industrialised country influenced by a Western lifestyle
but at the same time, it shows a low CHD mortality rate. When compared
on the basis of age-standardised to world standard population, the
CHD mortality of Japan (at 28 per 100,000) is about one-sixth that
of New Zealand (at 173) and one-fifth that of Australia (140) for
both sexes14. Regional differences exist in that age-adjusted
CHD mortality is higher in urban prefectures such as Tokyo and Osaka
than in the rural counterparts27.
Table 4. Cardiovascular disease mortality rates
in Asia Pacific countries (for all ages, per 100,000 population).
| |
Male
|
Female< 1000 /b>
|
| |
Coronary heart disease
|
Cerebro vacular disease
|
Circulatory system diseases
|
Coronary heart disease
|
Cerebro vacular disease
|
Circulatory system diseases
|
| New Zealand 1991 |
228
|
62
|
335
|
173
|
95
|
336
|
| Australia 1992 |
191
|
55
|
304
|
161
|
80
|
312
|
| Singapore 1991 |
104
|
55
|
190
|
77
|
69
|
177
|
| Hong Kong 1991 |
56
|
49
|
140
|
37
|
56
|
1000
142
|
| Japan 1992 |
45
|
92
|
247
|
38
|
100
|
256
|
| China 1990
|
49
24
|
126
104
|
222
177
|
46
21
|
117
104
|
222
182
|
| Philippines 1991* |
38
|
30
|
142
|
24
|
22
|
107
|
| Malaysia 1990** |
31
|
15
|
69
|
19
|
16
|
45
|
| Thailand 1992* |
24
|
15
|
98
|
2 1000
|
9
|
60
|
Sources: WHO Health Statistics Annual, 1993 (ref 14);
*SEAMIC Health Statistics, 1993 (SEAMIC, 1995) (ref 19); ** Vital
Statistics Peninsular Malaysia, 1991 (ref 20).
Table 5. Cardiovascular disease mortality rates
in Asia Pacific countries. (age-standardised rates, per 100,000 population)*
| |
Male
|
Female
|
| |
cardio-vascular disease
|
coronary heart disease
|
cerebro vascular disease
|
cardio-vascular disease
|
coronary heart disease
|
cerebro vascular disease
|
| New Zealand 1992 |
268
|
173
|
46
|
159
|
84
|
43
|
| Singapore 1991 |
241
|
132
|
72
|
178
|
78
|
68
|
| Australia 1992 |
222
|
140
|
39
|
1000
139
|
73
|
35
|
| Japan 1992 |
157
|
28
|
58
|
101
|
15
|
40
|
* age-standardised to world standard population; Source:
World Health Statistics Annual, 1993 (ref 14)
CHD in China was once a disease of little significance,
but has become increasingly important. In 1958, Tung (as quoted in
Tao et al28) described "the uncommon occurrence
in China of atherosclerotic heart disease which comprised of only
7% to 12% of adult cardiac cases seen in hospitals and clinics".
The mortality rate attributed to CVD has increased from 86.2 per 100,000
in 1957 (12.1% of total deaths) to 214.3 per 100,000 in 1990 (35.8%
of all deaths)29. It is to be expected that a vast country
like China might have a very wide range of values for the incidence
of and mortality from CHD30. In the urban areas, CHD is
the leading cause of death and its mortality rate is twice as high
as in rural areas for both men and women. According to the Sino-MONICA
Project which commenced in 1983 to monitor the trends in morbidity
and mortality from CVD in China, CHD incidence is higher in the northern
provinces than in the southern areas29. Qingdao in the
northern province of Shandong had the highest incidence of CHD at
203 and 96 per 100,000 for men and women aged 35-74, respectively,
between 1985-89, compared to Chuxian in the south with one-tenth the
levels in Quingdao.
Mortality due to CVD has emerged as a major cause
of death in the last two decades in the Philippines, Malaysia, Indonesia
and China. In the Philippines, CVD was not among the ten leading causes
of death before 1962, but since 1964, it has become the second most
frequent cause of death after respiratory diseases31,32.
In Indonesia, CHD has replaced rheumatic heart disease as the most
prevalent diagnosis among patients admitted with CVD33.
In Peninsular Malaysia, CVD has become the leading
cause of death since 197020. In Malaysia and Singapore,
Indians are consistently reported to have the highest CHD mortality
rate among the other ethnic groups in those two countries namely,
Chinese and Malays. In 1990, the mortality rate for Indians in Peninsular
Malaysia was 51.8 per 100,000 (for all ages) compared to 25.5 and
14.4 for Chinese and Malays respectively34. In Singapore,
the age-adjusted death rate for CHD for Indian men is three times
higher than that for Chinese men and one and a half times that for
Malay men22. South Asians in other countries (for example,
England, Fiji, West Indies, South Africa and United States) have also
been shown to have a higher incidence of CHD compared with other ethnic
groups as reviewed by Rao and White35.
Among less socio-economically advanced countries in
the region less influenced by Western diet, CVD doe 1000 s not yet
rank as the leading cause of death. For example, in Papua New Guinea,
the major forms of heart disease are more typical of developing countries
(rheumatic heart disease, congenital heart disease and cardiomyopathy)36.
Lindeberg and Lundh37 also reported that CHD and stroke
appear to be absent among the traditional Melanesian horticulturalists
in Kitava, Trobriand Island and Papua New Guinea.
Figure 1 illustrates the CHD mortality rates of men
and women in the Asia Pacific countries. In general, men have a higher
CHD mortality rate than women when considered for all ages. In older
age groups, however, the sex mortality differential narrows as exemplified
by the case in Malaysia in 1990. On an age-standardised basis, the
sex mortality ratio for ages 35-49 was 4.7 and it decreased to 1.9
for ages 50 and above34.
Figure 1. Coronary heart disease mortality
in Asia Pacific countries.

Trends
in coronary heart disease mortality
The trend in CHD mortality in industrialised countries
was generally upward until the late 1960s38. CHD became
the leading cause of mortality for middle-aged and older people. Nonetheless,
the situation has reversed since the early 1970s with the CHD mortality
trend on the decline. For example in the Asia Pacific region, Thom11
reported that between 1969-78, Australia showed a decline of 24% for
men aged 45-64 years of age, and New Zealand decreased by 22%. Further
declines were shown between 1979-85 for men of this age group, with
decreases of 25% and 20% respectively for Australia, and New Zealand.
Women aged 45-64 in these three countries also experienced substantial
declines in CHD mortality during these two periods.
The decline in Australia has occurred in all age groups
but to a greater extent in women and younger age groups39.
The CHD death rates continue to decline at 3-5% per annum without
sign of tapering off (Table 6). Cardiovascular disease is no longer
the major cause of death among young and middle-aged Australian men
and women40. Most deaths in this group are due to cancer.
Nonetheless, CVD remains the major cause of death among the elderly
of both sexes.
In New Zealand, as in Australia, the greatest decline
was observed for younger age groups in males and females41.
However, it is noted that despite the significant magnitudes involved
in the decline of CHD mortality in both Australia and
New Zealand in the past two decades, CHD is still
the leading cause of death in these countries. By world standards,
CHD death rates in Australia and New Zealand remain high42.
Table 6. Changes in mortality rates of coronary
heart disease for ages 25-64 in Asia Pacific countries.
| |
Male (%)
|
Female (%)
|
| |
1970/74 - 1980/84
|
1980/84 -1985/89
|
1970/74 - 1980/84
|
1980/84 -1985/89
|
| Australia |
-39.1
|
-25.4
|
-42.0
|
-28.5
|
| New Zealand |
-27.9
|
-17.6
|
-29.2
|
-22.4
|
| Japan |
-13.2
|
-10.9
|
-33.6
|
-20.8
|
| Singapore |
+14.2
|
-21.2
|
+29.0
|
-2.5
|
| Malaysia* |
+25.5
|
+8.2
|
+63.5
|
+19.4
|
Sources: WHO Health Statistics Annual, 1993 (ref 230);
*Vital Statistics Peninsular Malaysia, 1974-91 (ref 21)
In comparison, while the CHD mortality of Japan increased
in the 1950s until about 1967, and thereafter declined for both men
and women, the CHD mortality rate in Japan has been at a low level
since the 1950s43. The current CHD mortality rate of Japan
is less than one quarter that of Australia and one-fifth that of New
Zealand. The declining trend in Japan shows women and younger age
groups making earlier starts and clearer declines27,44.
Hong Kong and Singapore are examples of affluent Asian
countries with distinct Western influences on their dietary habits
and lifestyles. Both countries experienced an increase in CHD mortality
in the 1970s. The secular trend in Hong Kong between 1970-79 showed
a significant increase of 1.7% each year for men and 1.9% for women
for all ages23. The increase for Singapore men was 14.2%
and 29% for women between 1970/74-1980/84 (Table 6). Thereafter, both
countries have shown a downward trend in their CHD mortality trends.
Hong Kong showed small declines of 0.5 1000 % and 0.3% per year for
men and women respectively, while Singapore experienced larger rates
of decline, especially for the men, that is, by 21.2% and 2.5% for
women. The sex mortality ratio for CHD in Singapore for ages 30-69
shifted from 3.5 in 1959/63 to 2.8 in 1979/83, reflecting a greater
decline for men during that period.
These two countries appear to be undergoing a decline
in CHD mortality about two decades later than in the United States,
Australia, New Zealand and Japan. Hughes45 pointed out
that the decline in Singapore seems to begin with a younger age group
for a successively earlier period, (1974-78 in ages 45-49 years; 1969-73
in ages 40-44 years, and 1964-68 in ages 35-39). This could be due
more to a cohort effect rather than due to a particular year of death.
While industrialised countries (Australia, New Zealand
and Japan) and the other affluent countries in the region (Singapore
and Hong Kong) are on the downward trend in CHD mortality, there are
other countries which appear to be maintaining an upward trend. Malaysia
and China are two such countries. The CHD mortality in Malaysia was
8.0 per 100,00 population for all ages in 1965 and this rate has been
on the rise, reaching 23 in 199134. The rise has been more
rapid for women, whose CHD mortality more than doubled between 1975-90
(from 6.1 to 13.6), compared to about 30% increase for men during
the same period.
The CHD trends for China are extrapolated from the
situations in the cities of Beijing, Shanghai and Guangzhou between
1976-86 as reported by Tao et al28. During this
period, the CHD death rates for ages 35-74 showed a steady increase
for Guangzhou and Shanghai, whereas there was no discernible change
for Beijing. Nonetheless, the level in Beijing in 1986 was three times
that of Shanghai and Guangzhou. When compared on an age-standardised
basis for men and women (aged 35-74) between urban Beijing and other
countries, Beijing has twice the rate of Japan but one-third that
of Australia.
Mortality
rates for cerebrovascular disease
Cerebrovascular disease or stroke remains the principal
cause of morbidity and mortality among adults in several Asian and
Pacific Island populations. China, Taiwan and Japan rank highest in
terms of stroke mortality in the region. The mortality rates for cerebrovascular
disease in these three countries stand close to 100 or higher per
100,000 population for men and women for all ages46 (Table
4). In China, stroke is the leading cause of death, while in Taiwan,
it currently ranks second, next to cancer, after being the main cause
of death for almost 20 years from 1963-198246. The major
type of stroke in Taiwan is cerebral infarction while for Japan and
China, it is cerebral haemorrhage47,48.
In Japan, twice as many men (2.1) and women (2.6)
die from stroke than from CHD28 (Table 4). In China, the
stroke to CHD mortality ratio ranges from about 2.5 in urban areas
to almost 5.0 in rural areas. Chonghua, Zhaosu and Yingkai29
reported that the incidence of stroke is four times that of acute
myocardial infarction in some areas in China. There are about five
million surviving stroke patients and some 1.3 million new cases occur
each year. In comparison, New Zealand and Australia have a stroke
to CHD mortality ratio of only 0.3 for men and about 0.6 for women.
There are geographic and socio-economic differentials
in stroke mortality just as for CHD mortality. In Taiwan, the mortality
rates are higher in the northern regions and in urban areas46.
Similarly, the northern provinces of China have a higher incidence
of and mortality rate from stroke then the south. There is a three
to fivefo 1000 ld difference between the mortality rates for the north
and the south for both men and women29. In Japan, workers
in agriculture, sales, transportation and service industries have
higher rates of cerebrovascular disease than those in managerial and
administrative positions27.
Countries in the region with a lower mortality rate
for stroke of between 50-100 per 100,000 population include New Zealand,
Australia, Singapore and Hong Kong. Their stroke mortality rates for
men in 1991/92 ranged from 39 per 100,000 population in Australia
and 72 for Singapore, and among women, the rates ranged from 34 per
100,000 population for Australia to 68 for Singapore14.
The next group of countries with the lowest level
of stroke mortality rate in the region are the Philippines, Malaysia
and Thailand49. Their stroke mortality rate is below 50
per 100,000 population. The question that arises is, as previously
mentioned with CHD mortality, whether the low stroke mortality rate
actually reflects the real situation, or is it due to under-reporting
of cases owing to a low level of medically certified death cases in
these countries.
Figure 2 shows the cerebrovascular mortality rates
of men and women in the region. Slightly more men than women die from
cerebrovascular disease when the stroke mortality rate between men
and women is compared on the basis of age-standardised to world population.
The stroke mortality female:male ratio in the region ranges from 0.7
for Japan and China, to 0.8 for Taiwan and Hong Kong and to 0.9 for
Australia, New Zealand and Singapore14,30. On an age-specific
basis, in 1991/92 for ages 25-64, the female:male ratio for stroke
mortality ranged from 0.6 for Japan to 0.7 for Singapore and 0.8 for
both Australia and New Zealand. The gap narrows in the older age category
of 64 years and above, where the female:male mortality ratio approached
0.9 for Japan and 1.2 for Singapore, Australia and New Zealand. This
indicates that women become more prone to stroke at older ages than
men. An epidemiologic study in Taiwan further demonstrated this trend46.
The sex ratio for the prevalence of stroke was found higher for men
for the younger ages from 36-64, but the ratio reached 1.0 for ages
65-74. However, for ages 75 and above, the prevalence for stroke was
again higher for men.
Figure 2. Cerebrovascular disease mortality
in Asia Pacific countries.

Trends
in cerebrovascular disease mortality
Some Asia Pacific countries with high mortality rates
for cerebrovascular disease have experienced a substantial quantum
of decline since 1970. Among the countries in the region with the
highest tertile of mortality for cerebrovascular disease (China, Taiwan
and Japan), Japan has undergone the most substantial decline since
1970 for both men and women (Table 7). The decline in Japan was 20.1%
for men and 22% for women in the 1980s. Taiwan has also experienced
a reduction in its stroke death rate, albeit less rapidly than Japan
during about the same period. Its decrease was 17.5% for men and 18.5%
for women between 1972 and 198350, as compared to 43.6%
and 42.4% for men and women respectively for Japan between 1970/74
and 1980/84.
Table 7. Changes in mortality rates of cerebrovascular
disease for ages 25-64 in Asia Pacific countries.
| |
Male (%)
|
Female (%)
|
| |
1970/74-1980/84
|
1980/84-1985/89
|
1970/74-1980/84
|
1980/84-1985/89
|
|
Australia
|
-43.7
|
-32.5
|
-51.9
|
-32.7
|
|
Japan
|
-43.6
|
-20.1
|
-42.4
|
-22.0
|
|
New Zealand
|
-38.7
|
-19.5
|
-42.8
|
-30.6
|
|
Singapore
|
-35.6
|
-22.7
|
-35.2
|
-26.5
|
|
Malaysia*
|
-15.6
|
-10.3
|
+3.1
|
-5.7
|
Sources: WHO Health Statistics Annual, 1993 (ref 14);
*Vital Statistics Peninsular Malaysia, 1974-92 (ref 21)
In Singapore, decline in cerebrovascular disease commenced
in early 1970 for males and mid-1970s for females51. Between
1969 and 1983, the decline was more marked in males than females for
ages above 40 years. This differential appears to have narrowed as
indicated in Table 6, which shows the declines
(a) New Zealand
In New Zealand, Jackson and Beaglehole41
attributed 38-51% of the decline in CHD mortality in men aged 35-64
between 1968-80 to reductions in per capita consumption of saturated
fats and dietary cholesterol and to decline in cigarette smoking.
Per capita consumption of cholesterol rose from about 650 mg per day
in 1955 to 740 mg in the early 1970s, after which it dropped to 615
mg in 1981. This drop is reflects a reduction in the consumption of
eggs, beef, mutton, butter and whole milk. Reduction in the consumption
of these foods also has led to a similar trend in the intake of saturated
fat in New Zealand. Intake of saturated fat peaked in 1963 and then
declined by 12% between 1968 and 1980 to a level of about 25 g per
head per day. Concomitant with this decline in saturated fat intake
has been a rise in polyunsaturated fat consumption derived mainly
from vegetable oils which increased by 73% between 1967 and 1978.
This has brought about an increase in the polyunsaturated: saturated
fat (P/S) ratio from 0.11 in the 1960s to 0.22 in 1980. This value
is still low, nonetheless, as compared with the ratios in other Asian
countries, and the value recommended by WHO for both industrialised
and developing countries (P/S >1.0) (WHO, 1990).
New Zealanders aged 18-24 have a mean cholesterol
level which is about 0.5 mmol/L higher than in Britain88.
Those aged 35-64 years have levels comparable with the North Karelia
province in Finland which has one of the highest CHD mortality rates
in the world. The high level of mean serum cholesterol persists in
New Zealand despite having experienced decreases in the 1970s and
1980s. For example, average serum cholesterol concentration declined
by 2.9-4.4% for men aged 35-64 years between 1968-198041.
The decline appears to have slowed down as in a more recent study
of men and women aged 40-64 years in Auckland, Jackson et al96
reported their mean serum cholesterol level declined by only about
1% between 1982-1987. In terms of the prevalence of hypercholesterolemia
(where serum cholesterol is 6.5 mmol/L or higher), New Zealand ranks
highest with 33% among males and 30% for females (Table 11).
(b) Australia
Thompson, Hobbs and Martin39 estimated
that dietary changes in fat since 1950 could have contributed to about
30% of Australias CHD mortality decline. Dietary cholesterol
intakes have also decreased by 18% between 1950 and 1985. This was
attributed to the decline in the consumption of meat, eggs and butter
by 14%, 38% and 60%, respectively between 1968/69 to 1984/85. During
the same period, the consumption of poultry, fish and table margarine
increased by 175%, 40% and 347% respectively.
The prevalence of hypercholesterolemia in Australia
1000 has been reported for various migrant populations, which show
a wide differential in CHD mortality rate. For example, migrants from
Western and Eastern Europe have about twice the mortality rates of
those from Southern Europe and Southeast Asia97. The diets
of Southern European migrants remain significantly different with
consumption of less dairy fat other than cheese, and more cereals,
vegetables and wine98. In contrast, Bennett99
reported that blood lipids, including total cholesterol, HLD and LDL-cholesterol
of various immigrant population groups were comparable with the levels
of native-born Australians, who were assessed by the 1989 Australian
National Heart Foundation (ANF) Survey90. This finding
suggests that blood lipids play little part in explaining CVD mortality
difference among Australian migrant groups. A similar finding was
reported by Hsu-Hage and Wahlqvist100 for Melbourne Chinese
and by Wilson et al101 for Greek-Australians, in
that the prevalence levels of hypercholesterolemia (serum cholesterol
6.5 mmol/L or higher) in these migrant populations were found to approximate
the mean level for the NHF sample aged 25-64 years. Whilst it is generally
accepted that CVD is related to a number of risk factors, the relationship
is exceedingly complex and is made more so by the additional factors
associated with immigration.
(c) Singapore
The trend for available fat in Singapore is reflected
in its CHD mortality pattern. As pointed out previously, Singapore
ranks closer to Australia than the other countries in South East Asia
with regards to CHD mortality rates, but unlike Australia and New
Zealand which have experienced substantial declines in CHD mortality
commencing in the mid-1960s, Singapore, resembling Hong Kong, commenced
its decline about a decade later in the 1970s. Between 1961 to 1980,
per capita availability for meat, eggs, milk, and animal oils and
fats increased by 135.1%, 79.3%, 35.4% and 72.9% respectively102.
Given the increased intake of saturated fat in the 1980s, the P/S
ratio for adult Singapore Chinese is rather low ranging from 0.3 to
0.5. However, while the P/S ratio of Singapore approaches that of
the Framingham adults85, the dietary cholesterol intake
for Singapore remains relatively lower at 131-222 mg per capita per
day compared to 415 mg for males and 260 mg for females in Framingham.
The three main ethnic groups in Singapore namely,
Chinese, Malays and Indians show differences in risk factor levels.
Malays show the highest rate for mean systolic blood pressure and
cigarette smoking, while Indians have the lowest mean HDL-cholesterol
concentration91, there was no ethnic difference in mean
total cholesterol, LDL-cholesterol as total triglyceride concentration.
Chinese have the highest ratio of apo A-I/apo B103. It
is suggested that the higher level of apo B and lower levels of HDL-cholesterol,
apo A-I and apo A-II in Indians contribute towards this group having
the highest incidence of CHD among the ethnic groups in Singapore.
(d) Hong Kong
The current relatively low rate of CHD mortality in
Hong Kong ranks it in the middle tertile among Asia Pacific countries.
However, its dietary pattern points towards future increased CHD incidence
as reflected by an upward trend in the apparent consumption of animal
products and the proportion of energy from fat (35.5%) approaching
the levels in Australia and New Zealand. Moreover, the dietary habits
of young children and adolescents may place these children at future
risk of diet-related chronic diseases including CHD unless curbed
by interventions. Prominent dietary preferences of the younger generation
include Westernised fast foods (burgers, pizzas, French fries), so
1000 ft drinks, bakery goods and dairy products. Given such dietary
preferences, Lee et al104 showed that the diet of
12-year old adolescents in Hong Kong is high in fat (28.8% of total
energy), saturated fat (above 10% of energy), and cholesterol (mean
481 mg/day) whereas the P/S ratio is low (0.43). A similar finding
was reported by Leung et al105 in that, compared
with seven-year old children in Southern China, Hong Kong children
of the same age consumed 37% more fat daily and showed a higher mean
plasma cholesterol level (5.18 mmol/L versus 3.89). Hong Kong children
consumed more milk, eggs, French fries, and fast foods than their
counterparts in Southern China.
(e) Japan
In Japan too, there are indications that the fat intake
is considerably higher among young children. For example, girls aged
ten to eleven years were found to be consuming fat amounting to 34%
of total energy106. This amount approaches the level (37%)
which is typical of the intake of the general American population.
The traditional Japanese diet is high in carbohydrates,
low in fats and high in seafood contributing to a relatively high
P/S ratio. It typically is comprised of boiled rice, fermented soybean
paste ("miso") used in soup, fish, salty pickles ("tsukemono"),
and non-green-yellow vegetables107. However, the Japanese
dietary habits have become more Westernised and per capita consumption
of meat, eggs, milk and diary products have been on the rise since
1955, albeit more slowly since 197243. The annual National
Nutrition Surveys of Japan indicate that carbohydrate intake has been
reduced remarkably from 81% of total energy in 1949 to 50% in 1988.
Animal protein intake increased by 13.3% between 1960 and 1985, while
fat consumption increased by 130% during the same period108.
Consequently, since the second World War, fat intake in Japan has
increased from about 7% of total energy to currently about 25%92.
The mean MUFA intake in Japan was 20.3 g/day or 39% of total fatty
acids, which is less than half the level in United States.
Dietary cholesterol has increased over the years to
a level of 363 mg per capita per day in 1989. This level is double
that of China and almost three times that of Singapore. Nonetheless,
as Japan ranks lowest among the industrialised countries in mortality
rates for CHD, it is suggested that this situation could be that "the
Japanese people continue to eat rice as the main dish while balancing
animal and vegetable foods, reducing salt consumption, eating large
amounts of fish and incorporating meat and milk into their meal planning"109.
They also have a uniquely high intake of green tea, with its anti-oxidant
properties110
Salt intake in Japan declined steadily from a level
of 14.5g per day in 1972 to 12g in 1987108. This factor
together with the substantial decline in systolic and diastolic blood
pressure levels for every age-sex group between the 1960s and 1980s
are believed to have contributed to the significant decline in cerebrovascular
disease during this period47. In comparison, in China,
potassium rather than sodium was found to relate more directly with
blood pressure111. Hatano27 provided evidence
for the decrease in hypertension as a more important risk factor than
hyperlipidaemia for CHD decline.
It is noteworthy that Japan, although it has one-fifth
the level of CHD mortality rate of New Zealand, has the next highest
prevalence of hypercholesterolemia in the region with levels that approach
those in New Zealand namely, 29.4% and 30.4% for males and females
respectively (Table 12). It is reported that i 1000 n the past decade
or so, serum cholesterol has increased by 1 mg/dL each year106.
Autopsy data for Japanese males and females under 40 years show evidence
of fatty streaks in more than 20% of those aged 10-19 years, and increasingly
more complicated lesions were found with increasing age. Goto106
provided evidence of the association of early development of fatty
streaks and fibrous plaques with an increased in myocardial infarction
occurring in younger persons.
(f) China
The dietary pattern of China in general is less Westernised
compared with several Asia Pacific countries. The Chinese diet is
low in total fat, saturated fat and cholesterol with a high P/S ratio,
despite recent increases in the consumption of energy. The first Chinese
Total Diet Study undertaken in 1990, showed the mean fat intake accounted
for 21.2% of total energy which had increased from 15.9% in 1982112.
This proportion of fat energy is relatively low compared with nearly
40% for countries like New Zealand, Australia and Hong Kong (Table
8). Dietary total fat, SFA, PUFA and cholesterol are higher in the
urban than the rural areas113. Lee et al104
showed that the intake of MUFA in China in both men (29.1g/day) and
women (22.4 g/day) was less than two-thirds that (45.7 and 38.5 g/day
respectively) in the United States. The Chinese Total Diet Study112
reported a similar mean level of MUFA intake level of MUFA at 22.2
g/day which amounted to 44% of total fatty acids.
In terms of per capita total available animal fat,
China shows a relatively low level among the Asia Pacific countries
(22.3g per day) (Table 9). Urban-rural dietary differences are marked
especially in fat intake. The P/S ratio of the Chinese diet remains
high at 1.0, which is double that of United States and four times
that of New Zealand. The dietary cholesterol contribution also remains
low at 173 mg/day, being derived principally from eggs (54.4%) and
meat (28.9%). The per capita availability of both eggs and meat, is
predominantly pork, and relatively low in the region (Table 9). However,
as the Chinese Total Diet indicates, fat intake from animal food is
on the increase, having risen from 36.3% or total fat in 1982 to 53%
in 1990. This trend may be expected to persist, especially in urban
areas, given the current high level of economic development, including
the spread of Western dietary influences.
China has a similar level of CHD mortality rate to
Japan, but it shows a much lower prevalence of hypercholesterolaemic
males and females (1.0% for each case in Table 11), coupled with a
low average plasma cholesterol level. Mean values for plasma total
cholesterol and LDL-cholesterol for all counties combined were 3.28
and 1.66 mmol/L respectively114. Liu et al113
reported mean plasma cholesterol, triglycerides, and LDL-cholesterol
concentrations were higher in the urban population compared to the
corresponding rural population. The mean total cholesterol levels
in both sectors were low (4.7 mmol/L and 4.2 mmol/L in urban and rural
males, respectively).
It was suggested in the Multiple Risk Factor Intervention
Trial (MRFIT)115 that low cholesterol may cause intracranial
haemorrhage leading to stroke mortality. However, this has been refuted
by Chen et al114,116 who reported that there is
no strong association between low cholesterol levels and haemorrhagic
stroke mortality rates. Additional evidence is provided by Wexun et
al117. The blood lipids of subjects in 65 rural counties
who consumed a low-fat and low-protein diet throughout their entire
life were presented. It is of interest that no significant correlation
between the various cholesterol fractions (LDL, HDL and total cholesterol)
and mortality f 1000 rom CHD, cerebrovascular disease and hypertensive
heart disease was found. Rather, a significant inverse association
between erythrocyte oleate (18:1; n-9) and CVD mortality, especially
CHD, was found. Also, rice intake was positively correlated with erythrocyte
oleate. The authors suggested a protective role for oleate through
the reduction in the synthesis of proaggregatory thromboxanes derived
from arachidonate, in a similar manner to the mechanism for the protective
effect of n-3 fatty acid-rich oils on platelet aggregation. Thus,
CVD mortality in China may be more related to thrombotic tendency
than to arterial cholesterol deposition117.
(g) Taiwan
A dietary assessment of Taiwanese subjects showed
fat intake by men was 34% of total energy and 37% for women94.
These levels are comparable with the result obtained from the 1986-88
Taiwan Dietary Survey, which reported an average intake of 36% fat
mainly from soybean oil and pork. The mean MUFA intake in Taiwan was
29.9 g/day in men and 23.9 g/day in women or about 36% of total fatty
acids for both sexes. This level is about the same as in Japan but
lower than that in China.
The daily per capita cholesterol intake for Taiwan
of 338 mg for men and 258 mg for women118 is also higher
than the average intake of 179 mg for China. Nonetheless, in Taiwan,
the intake of polyunsaturated fat (26 g for men and 21 g for women)
is higher than the intake of saturated fat (21 g for men and 17 g
for women). This renders the P/S ratio for Taiwan (1.4) even higher
than that for Japan and China (1.0).
(h) Malaysia
The dietary pattern in Malaysia is available from
food balance sheets for the period between 1961/63 until 1992. Food
consumption data are limited to cross-sectional studies involving
a small number of subjects. As expected of a rapidly developing country
with substantial Western influence on dietary habits